Discovering & Developing a New Era of Cardiometabolic Therapeutics

Harness Emerging Targets, Novel Mechanisms of Action & Develop Differentiated Modalities that Improve Muscle Preservation, Patient Adherence & Efficacy

The obesity therapeutics landscape is undergoing a radical expansion, fueled by groundbreaking late-stage trials for Novo Nordisk's amycretin and Metsera's exciting early data for its amylin-targeting shot. Underscored by new insights into Eli Lilly's tirzepatide's cardiovascular benefits, the field is witnessing a paradigm shift beyond GLP-1s to novel mechanisms, combination therapies, and oral formulations. This new era of innovation promises wider accessibility and improved patient outcomes, makes the 2nd Innovation in Obesity Therapeutics Summit the essential forum for accelerating the next wave of treatment.

This year, we're diving deep into game-changing potential of novel mechanisms of action, muscle-preserving strategies, and multi-agonist therapies. Hear from the titans of the pharmaceutical industry, including Novo Nordisk, Eli Lilly and Boehringer Ingelheim, as well as innovative biotechs like Veru, Supercede Therapeutics, and Rivus Pharmaceuticals, who will share their groundbreaking research and strategies. The pressure is on to continue work on developing best-in-class treatments that transform patient lives.

Don't miss this pivotal opportunity to network with 60+ leading scientists and drug development experts in the field of obesity, forge crucial collaborations, and be part of the solution. The future of obesity therapeutics is being written now – be a part of it!

Broad perspective on the future of obesity treatments from both scientific presenters and service providers.

Adipo Therapeutics

adipo therapeutics

Broad perspective on the future of obesity treatments from both scientific presenters and service providers.

Boehringer Ingelheim

Boehringer_Ingelheim

Explore the 2025 Full Event Guide

  • Get a full overview of the agenda, speakers, and session topics in one place
  • Preview featured case studies that we’ll be shining a light on throughout the event
  • Discover exclusive content such as keynote highlights, attendee benefits and more
  • Share easily with colleagues or decision-makers to assess and mobilize interest
event guide image

2025 Partners

Expertise Partners

Innovation Partner

event guide image
Quick Download

2025 Attending Companies Included

Pfizer
Boehringer Ingelheim
Regeneron
University of Minnesota
Equator Therapeutics
Fractyl Health
Rhythm Pharmaceuticals
Adipo Therapeutics
Terns Pharmaceuticals
speaker talk

Explore the Agenda

Hear the latest industry breakthroughs and gain exclusive insights during our packed agenda, interactive roundtables, and panel discussions.

exhibition talk

Partner With Us

Position yourself alongside other leading solution providers to ensure your brand is at the heart of biopharma deals.

audience listening

Join Biopharma Experts

Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.